- Foamix Ltd. Company News Section

Foamix Ltd. Information
  • Dov Tamarkin
  • Holzman 2
  • Phone: 97289316233
  • URL:
  • Headquartered in Rehovot, Israel, Foamix Ltd. is a specialty pharmaceutical company focused on the development of topical foam products for prescription, OTC and cosmetic applications.
    By incorporating a drug in foam, we derive an advanced, patent protected product with improved convenience, higher compliance and better efficiency.
Foamix Ltd. Press Release -

  • Telormedix, Foamix Receive EU Funding for the Development of a New Topical Skin Cancer Treatment
  • Telormedix SA and Foamix Ltd., two clinical stage biopharmaceutical companies focused on TLR7 agonists in the treatment of cancer and inflammatory diseases and on topical foam delivery systems announced that they have raised funding to coordinate a two-year research project aimed at developing a new skin cancer topical treatment based on a foam formulation of one of the Company's drug candidates.
  • June 07, 2012
  • Foamix Fortifies its Patent Position in Mexico
  • Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, announced today that the Company has obtained another granted patent in Mexico.
  • June 04, 2012
  • Arkin and Foamix to Develop an Innovative Acne Foam
  • Herzliya, Israel and Rehovot, Israel - Arkin Holdings and Foamix today announced that they have established a collaboration to develop and commercialize an innovative topical foam to treat patients with acne vulgaris and related disorders.
  • May 27, 2011